550O Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study
R-H. Xu, Ye Xu, Dongyao Yan, Pamela N. Münster, Dan Ruan, Yanhong Deng, Hongming Pan, Craig Underhill, Gary Richardson, Ina Nordman, Kyung-Woo Lee, Suocheng Wei, X. Li, Jing Shan, Guohong Han, Steve Henderson, Xinxin Xie, Z. Xiang, Z. Shi, Li Zhang
Topics & Concepts
KRASMedicineCetuximabInternal medicineColorectal cancerOncologyPhases of clinical researchCancerGastroenterologyClinical trialColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsGenetic factors in colorectal cancer